Form 8-K - Current report:
SEC Accession No. 0000849146-24-000064
Filing Date
2024-08-26
Accepted
2024-08-26 16:26:04
Documents
15
Period of Report
2024-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20240826.htm   iXBRL 8-K 30115
2 EX-99.1 lfvn-pressreleasedirector.htm EX-99.1 13111
6 image_0a.jpg GRAPHIC 14910
  Complete submission text file 0000849146-24-000064.txt   195978

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20240826.xsd EX-101.SCH 1926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20240826_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20240826_pre.xml EX-101.PRE 13066
17 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20240826_htm.xml XML 2798
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 241241706
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)